HCA Healthcare Stock-Based Compensation Growth & History (HCA)
HCA Healthcare's stock-based compensation was $401.0M for fiscal 2025.
View full HCA Healthcare company overviewHCA Healthcare annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $401.0M | $41.0M | +11.39% |
| 2024 | 2024-12-31 | $360.0M | $98.0M | +37.40% |
| 2023 | 2023-12-31 | $262.0M | −$79.0M | −23.17% |
| 2022 | 2022-12-31 | $341.0M | −$99.0M | −22.50% |
| 2021 | 2021-12-31 | $440.0M | $78.0M | +21.55% |
| 2020 | 2020-12-31 | $362.0M | $15.0M | +4.32% |
| 2019 | 2019-12-31 | $347.0M | $79.0M | +29.48% |
| 2018 | 2018-12-31 | $268.0M | −$2.0M | −0.74% |
| 2017 | 2017-12-31 | $270.0M | $19.0M | +7.57% |
| 2016 | 2016-12-31 | $251.0M | $12.0M | +5.02% |
| 2015 | 2015-12-31 | $239.0M | $76.0M | +46.63% |
| 2014 | 2014-12-31 | $163.0M | $50.0M | +44.25% |
| 2013 | 2013-12-31 | $113.0M | $57.0M | +101.79% |
| 2012 | 2012-12-31 | $56.0M | $30.0M | +115.38% |
| 2011 | 2011-12-31 | $26.0M | −$6.0M | −18.75% |
| 2010 | 2010-12-31 | $32.0M | −$8.0M | −20.00% |
| 2009 | 2009-12-31 | $40.0M | — | — |
HCA Healthcare quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $85.0M | −$14.0M | −14.14% |
| Q1 2026 | 2026-03-31 | $86.0M | −$12.0M | −12.24% |
| Q4 2025 | 2025-12-31 | $100.0M | $15.0M | +17.65% |
| Q3 2025 | 2025-09-30 | $104.0M | $28.0M | +36.84% |
| Q2 2025 | 2025-06-30 | $99.0M | −$13.0M | −11.61% |
| Q1 2025 | 2025-03-31 | $98.0M | $11.0M | +12.64% |
| Q4 2024 | 2024-12-31 | $85.0M | $28.0M | +49.12% |
| Q3 2024 | 2024-09-30 | $76.0M | $4.0M | +5.56% |
| Q2 2024 | 2024-06-30 | $112.0M | $56.0M | +100.00% |
| Q1 2024 | 2024-03-31 | $87.0M | $10.0M | +12.99% |
| Q4 2023 | 2023-12-31 | $57.0M | −$26.0M | −31.33% |
| Q3 2023 | 2023-09-30 | $72.0M | −$15.0M | −17.24% |
| Q2 2023 | 2023-06-30 | $56.0M | −$29.0M | −34.12% |
| Q1 2023 | 2023-03-31 | $77.0M | −$9.0M | −10.47% |
| Q4 2022 | 2022-12-31 | $83.0M | −$16.0M | −16.16% |
| Q3 2022 | 2022-09-30 | $87.0M | −$28.0M | −24.35% |
| Q2 2022 | 2022-06-30 | $85.0M | −$44.0M | −34.11% |
| Q1 2022 | 2022-03-31 | $86.0M | −$11.0M | −11.34% |
| Q4 2021 | 2021-12-31 | $99.0M | −$34.0M | −25.56% |
| Q3 2021 | 2021-09-30 | $115.0M | $34.0M | +41.98% |
| Q2 2021 | 2021-06-30 | $129.0M | $63.0M | +95.45% |
| Q1 2021 | 2021-03-31 | $97.0M | $15.0M | +18.29% |
| Q4 2020 | 2020-12-31 | $133.0M | $49.0M | +58.33% |
| Q3 2020 | 2020-09-30 | $81.0M | −$24.0M | −22.86% |
| Q2 2020 | 2020-06-30 | $66.0M | −$30.0M | −31.25% |
| Q1 2020 | 2020-03-31 | $82.0M | $20.0M | +32.26% |
| Q4 2019 | 2019-12-31 | $84.0M | $20.0M | +31.25% |
| Q3 2019 | 2019-09-30 | $105.0M | $35.0M | +50.00% |
| Q2 2019 | 2019-06-30 | $96.0M | $22.0M | +29.73% |
| Q1 2019 | 2019-03-31 | $62.0M | $2.0M | +3.33% |
| Q4 2018 | 2018-12-31 | $64.0M | −$11.0M | −14.67% |
| Q3 2018 | 2018-09-30 | $70.0M | $15.0M | +27.27% |
| Q2 2018 | 2018-06-30 | $74.0M | $7.0M | +10.45% |
| Q1 2018 | 2018-03-31 | $60.0M | −$13.0M | −17.81% |
| Q4 2017 | 2017-12-31 | $75.0M | $20.0M | +36.36% |
| Q3 2017 | 2017-09-30 | $55.0M | −$12.0M | −17.91% |
| Q2 2017 | 2017-06-30 | $67.0M | $3.0M | +4.69% |
| Q1 2017 | 2017-03-31 | $73.0M | $8.0M | +12.31% |
| Q4 2016 | 2016-12-31 | $55.0M | −$13.0M | −19.12% |
| Q3 2016 | 2016-09-30 | $67.0M | −$1.0M | −1.47% |
| Q2 2016 | 2016-06-30 | $64.0M | $9.0M | +16.36% |
| Q1 2016 | 2016-03-31 | $65.0M | $17.0M | +35.42% |
| Q4 2015 | 2015-12-31 | $68.0M | $23.0M | +51.11% |
| Q3 2015 | 2015-09-30 | $68.0M | $27.0M | +65.85% |
| Q2 2015 | 2015-06-30 | $55.0M | $15.0M | +37.50% |
| Q1 2015 | 2015-03-31 | $48.0M | $11.0M | +29.73% |
| Q4 2014 | 2014-12-31 | $45.0M | $13.0M | +40.63% |
| Q3 2014 | 2014-09-30 | $41.0M | $11.0M | +36.67% |
| Q2 2014 | 2014-06-30 | $40.0M | $12.0M | +42.86% |
| Q1 2014 | 2014-03-31 | $37.0M | $14.0M | +60.87% |
| Q4 2013 | 2013-12-31 | $32.0M | $15.0M | +88.24% |
| Q3 2013 | 2013-09-30 | $30.0M | $14.0M | +87.50% |
| Q2 2013 | 2013-06-30 | $28.0M | $14.0M | +100.00% |
| Q1 2013 | 2013-03-31 | $23.0M | $14.0M | +155.56% |
| Q4 2012 | 2012-12-31 | $17.0M | $15.0M | +750.00% |
| Q3 2012 | 2012-09-30 | $16.0M | $8.0M | +100.00% |
| Q2 2012 | 2012-06-30 | $14.0M | $6.0M | +75.00% |
| Q1 2012 | 2012-03-31 | $9.0M | $1.0M | +12.50% |
| Q4 2011 | 2011-12-31 | $2.0M | −$6.0M | −75.00% |
| Q3 2011 | 2011-09-30 | $8.0M | $0 | 0.00% |
| Q2 2011 | 2011-06-30 | $8.0M | $0 | 0.00% |
| Q1 2011 | 2011-03-31 | $8.0M | $0 | 0.00% |
| Q4 2010 | 2010-12-31 | $8.0M | — | — |
| Q3 2010 | 2010-09-30 | $8.0M | — | — |
| Q2 2010 | 2010-06-30 | $8.0M | — | — |
| Q1 2010 | 2010-03-31 | $8.0M | — | — |
HCA Healthcare stock-based compensation trends
Over the last five fiscal years, HCA Healthcare's stock-based compensation increased from $362.0M to $401.0M, a change of $39.0M. The latest reported quarter, Q2 2026, shows $85.0M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCA Healthcare source filings ↗